Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

24 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 711,389 shares of 13,831,528 outstanding shares and own 5.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (275,656 shares), RENAISSANCE TECHNOLOGIES LLC (125,828 shares), BlackRock, Inc. (73,746 shares), GEODE CAPITAL MANAGEMENT, LLC (68,890 shares), MORGAN STANLEY (64,346 shares), STATE STREET CORP (20,543 shares), Parallel Advisors, LLC (15,228 shares), DIMENSIONAL FUND ADVISORS LP (15,015 shares), NORTHERN TRUST CORP (12,171 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (12,127 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.